Compare Mahindra Manulife Mid Cap Fund vs Invesco India Mid Cap Fund
Risk
Very High
Very High
Rating
4.0
4.0
Min SIP Amount
₹500
₹100
Expense Ratio
2.36
2.65
NAV
₹34.85
₹180.84
Fund Started
08 Jan 2018
15 Feb 2007
Fund Size
₹4098.63 Cr
₹9895.34 Cr
Exit Load
Exit load of 1% if redeemed within 3 months.
Exit load for units in excess of 10% of the investment, 1% will be charged for redemption within 1 year.
1 Year
11.16%
12.46%
3 Year
25.64%
27.05%
5 Year
21.17%
21.86%
Equity
97.16%
99.05%
Cash
2.84%
0.95%
Top 10 Holdings
Glenmark Pharmaceuticals Ltd. | 3.42% |
The Federal Bank Ltd. | 3.03% |
Indusind Bank Ltd. | 2.91% |
Indus Towers Ltd. | 2.51% |
Max Financial Services Ltd. | 2.45% |
JSW Energy Ltd. | 2.42% |
AIA Engineering Ltd. | 2.41% |
Kei Industries Ltd. | 2.38% |
Astral Ltd. | 2.37% |
Indian Bank | 2.35% |
The Federal Bank Ltd. | 5.85% |
BSE Ltd. | 5.15% |
AU Small Finance Bank Ltd. | 5.06% |
Prestige Estates Projects Ltd. | 4.76% |
Max Healthcare Institute Ltd. | 4.64% |
Swiggy Ltd. | 4.31% |
Interglobe Aviation Ltd. | 4.16% |
L&T Finance Ltd. | 4.09% |
Glenmark Pharmaceuticals Ltd. | 4.02% |
Global Health Ltd. | 3.91% |
Name
-
-
Start Date
-
-
Description
The scheme seeks to generate long term capital appreciation & provide long-term growth opportunities by investing in a portfolio constituted of equity & equity related securities and derivatives predominantly in mid cap companies.
The scheme seeks to generate capital appreciation by investing predominantly in Midcap companies
Launch Date
08 Jan 2018
15 Feb 2007
